Landmark UK-US pharmaceuticals deal to safeguard medicines access and drive vital investment for UK patients and businesses

Office for Artificial Intelligence UK Published: 2025-12-01 00:00:00

Milestone deal secures UK’s medicines access for patients, with a wide range of groundbreaking new treatments to reach NHS front-line quicker.

No full content stored. Use “Open Source” to read the original.

Open Source →

Recommended reads

Egg-cellent time for chatting with your kids about what they're seeing online this Easter From UK

As millions of children enjoy the Easter holidays, the government is stepping up to take the pressure off parents battling to keep their children safe online

Office for Artificial Intelligence · UK 2026-04-03

Policy paper: UK-US arrangement on pharmaceutical trade and pricing From UK

Shared UK and US commitments to improve access to medicines, support pharmaceutical innovation and grow trade in the life sciences sector.

Office for Artificial Intelligence · UK 2026-04-02

NHS patients and British businesses to benefit from historic changes to medicines access following pharmaceutical partnership with USA From UK

New partnership accelerates NHS patients' access to new medicines and will see UK benefit from greater life sciences industry investment

Office for Artificial Intelligence · UK 2026-04-02

Landmark UK-US pharmaceuticals deal to safeguard medicines access and drive vital investment for UK patients and businesses

Landmark UK-US pharmaceuticals deal to safeguard medicines access and drive vital investment for UK patients and businesses